Literature DB >> 16868790

[Diagnosis and therapy of sepsis].

K Reinhart1, F M Brunkhorst, H-G Bone, H Gerlach, M Gründling, G Kreymann, P Kujath, G Marggraf, K Mayer, A Meier-Hellmann, C Peckelsen, C Putensen, F Stüber, M Quintel, M Ragaller, R Rossaint, N Weiler, T Welte, K Werdan.   

Abstract

A recent survey conducted by the publicly funded Competence Network Sepsis (Sep- Net) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approx. 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approx. 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organisation of the German health care system. Priority was given to the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy. The guidelines development process was carefully planned and strictly adhered to according to the requirements of the Working Group of Scientific Medical Societies (AWMF).

Entities:  

Mesh:

Year:  2006        PMID: 16868790     DOI: 10.1007/s00392-006-0414-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  291 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group.

Authors:  A Esteban; I Alía; F Gordo; R Fernández; J F Solsona; I Vallverdú; S Macías; J M Allegue; J Blanco; D Carriedo; M León; M A de la Cal; F Taboada; J Gonzalez de Velasco; E Palazón; F Carrizosa; R Tomás; J Suarez; R S Goldwasser
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

3.  Guidelines for treatment of candidiasis.

Authors:  Peter G Pappas; John H Rex; Jack D Sobel; Scott G Filler; William E Dismukes; Thomas J Walsh; John E Edwards
Journal:  Clin Infect Dis       Date:  2003-12-19       Impact factor: 9.079

4.  Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection.

Authors:  G W Tetteroo; J H Wagenvoort; A Castelein; H W Tilanus; C Ince; H A Bruining
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

5.  Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill.

Authors:  J C Stothert; D A Simonowitz; E P Dellinger; M Farley; W A Edwards; A D Blair; R Cutler; C J Carrico
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

6.  Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

Authors:  M G Petri; J König; H P Moecke; H J Gramm; H Barkow; P Kujath; R Dennhart; H Schäfer; N Meyer; P Kalmar; P Thülig; J Müller; H Lode
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

7.  Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.

Authors: 
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

8.  Response of critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption. Relationship to outcome.

Authors:  M A Hayes; E H Yau; A C Timmins; C J Hinds; D Watson
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

9.  Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.

Authors:  Robert W Taylor; Janice L Zimmerman; R Phillip Dellinger; Richard C Straube; Gerard J Criner; Kenneth Davis; Kathleen M Kelly; Thomas C Smith; Robert J Small
Journal:  JAMA       Date:  2004-04-07       Impact factor: 56.272

10.  Protocol-directed weaning from mechanical ventilation: clinical outcome in patients randomized for a 30-min or 120-min trial with pressure support ventilation.

Authors:  Andreas Perren; Guido Domenighetti; Simonetta Mauri; Franco Genini; Nicoletta Vizzardi
Journal:  Intensive Care Med       Date:  2002-07-13       Impact factor: 17.440

View more
  6 in total

1.  [Production of guidelines by the German Society for Cardiology--Heart and Circulation Research].

Authors:  A Osterspey
Journal:  Clin Res Cardiol       Date:  2006-12       Impact factor: 5.460

2.  Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications.

Authors:  Karl Werdan; Anja Oelke; Stefan Hettwer; Sebastian Nuding; Sebastian Bubel; Robert Hoke; Martin Russ; Christine Lautenschläger; Ursula Mueller-Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

3.  Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium.

Authors:  Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

4.  Immunonutrition with long-chain fatty acids prevents activation of macrophages in the gut wall.

Authors:  Friederike Eisner; Petra Jacob; Julia-Stefanie Frick; Maximilian Feilitzsch; Julia Geisel; Mario H Mueller; Markus A Küper; Helen E Raybould; Ingmar Königsrainer; Jörg Glatzle
Journal:  J Gastrointest Surg       Date:  2011-03-08       Impact factor: 3.452

5.  [Indocyanine green elimination for the evaluation of liver function: prognostic value in patients with community-acquired sepsis].

Authors:  S A Kaulen; C Hübner; J Mieth; K Spindler; R Schwab; R Wimmer; J Wilhelm; M Amoury; M Girndt; K Werdan; H Ebelt
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-09-03       Impact factor: 0.840

6.  MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-κB Pathway.

Authors:  Binzhen Chen; Jia Han; Shaoheng Chen; Rufeng Xie; Jie Yang; Tongming Zhou; Qi Zhang; Rong Xia
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.